The Electrospider 3D Bioprinter combines high-end robotics with multiple bioprinting techniques and innovative software to deliver a machine capable of moving the industry towards the goal of generating truly useful human tissue-constructs and, eventually, organ substitutes read more….
Tuscany is better known for its historic cultural influence than cutting-edge medical research, but it is there that the Venetian additive manufacturing specialist SolidWorld Group has delivered a major advance in 3D bioprinting. Its new Electrospider machine is a giant leap forward in the production of viable human tissue, which promises to revolutionise many areas of medicine in years to come.
Árima’s newly “greened” Guadalix logistics asset is delivering significant results for tenant, landlord and environment alike. The Madrid REIT is a good example of a landlord for whom the “green building revolution” is very much an opportunity, as opposed to the much-reported threat.
Vivisol, the home healthcare subsidiary of Italian gases group SOL SpA, is now a leading provider in Europe, and has been clocking in at around 70% of group EBIT. That makes the share one of the purest European plays on the growing trend for health authorities to de-hospitalize parts of in-patient care.
We caught up with Árima during their London roadshow. This Madrid green office REIT’s shares have held up somewhat better than the STOXX Real Estate Index, and one can see why. Despite the fact that Arima’s buildings and projects are classic “green premium” rentals, its market cap currently implies a yield of over 7%.